[HTML] springer.comFull View

[HTML][HTML] Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical Research, 2022 - Springer
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …
被引用次数：25 相关文章

Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma.

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical Research, 2022 - europepmc.org
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …
[HTML] nih.gov

[HTML][HTML] Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical Research, 2022 - ncbi.nlm.nih.gov
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …
[PDF] archive.org

[PDF][PDF] Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - 2022 - scholar.archive.org
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical Research, 2022 - search.proquest.com
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …
[PDF] rwth-aachen.de

[PDF][PDF] Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - 2022 - publications.rwth-aachen.de
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma.

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical Research, 2022 - search.ebscohost.com
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …
[HTML] biomedcentral.com

[HTML][HTML] Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical …, 2022 - mmrjournal.biomedcentral.com
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …

Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - Military Medical …, 2022 - pubmed.ncbi.nlm.nih.gov
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Y Lu, Y Gao, H Yang, Y Hu, X Li - 2022 - oa.tib.eu
Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical
resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory …